Boyd D. Obermeyer
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Treatment of Major Depression
- Cannabis and Cannabinoid Research
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Louis Lemberger (3 shared papers)Todd A. Gillespie (1 shared paper)Anthony Murphy (1 shared paper)Edward L. Mattiuz (1 shared paper)David E. Tupper (1 shared paper)Kelem Kassahun (1 shared paper)John T. Callaghan (5 shared papers)Alan Rubin (5 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)Clinical Chemistry (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)The Journal of Infectious Diseases (1 paper)Therapeutic Drug Monitoring (1 paper)
- Partner nations
- United StatesSwitzerlandSingapore
In The Last Decade
Boyd D. Obermeyer
14 papers receiving 386 citations
Peers
Comparison fields: 5 of 88
- Pharmacology 86
- Biological Psychiatry 23
- Psychiatry and Mental health 134
- Pharmacology 137
- Gastroenterology 28
Countries citing papers authored by Boyd D. Obermeyer
This map shows the geographic impact of Boyd D. Obermeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyd D. Obermeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyd D. Obermeyer more than expected).
Fields of papers citing papers by Boyd D. Obermeyer
This network shows the impact of papers produced by Boyd D. Obermeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyd D. Obermeyer. The network helps show where Boyd D. Obermeyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Boyd D. Obermeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Disposition and biotransformation of the antipsychotic agent olanzapine in humans. | 1997 | 187 |
| 2 | 1987 | 40 | |
| 3 | 1971 | 37 | |
| 4 | 1977 | 33 | |
| 5 | 1985 | 29 | |
| 6 | 1979 | 23 | |
| 7 | 1987 | 21 | |
| 8 | 1986 | 13 | |
| 9 | 1981 | 12 | |
| 10 | 1990 | 11 | |
| 11 | 1972 | 8 | |
| 12 | 1990 | 7 | |
| 13 | 1978 | 4 | |
| 14 | 1997 | 2 |
About Boyd D. Obermeyer
Boyd D. Obermeyer is a scholar working on Pharmacology, Pharmacology, Organic Chemistry, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 14 papers that have together received 427 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pharmaceutical studies and practices (2 papers), Gastroesophageal reflux and treatments (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Plant and fungal interactions (2 papers), Drug Solubulity and Delivery Systems (1 paper) and Analytical Chemistry and Chromatography (1 paper). The work is most often cited by research in Pharmacology (86 citations), Biological Psychiatry (23 citations), Psychiatry and Mental health (134 citations), Pharmacology (137 citations) and Gastroenterology (28 citations). Boyd D. Obermeyer has collaborated with scholars based in United States, Switzerland and Singapore. Frequent co-authors include Louis Lemberger, Todd A. Gillespie, Anthony Murphy, Edward L. Mattiuz, David E. Tupper, Kelem Kassahun, John T. Callaghan, Alan Rubin, Richard F. Bergstrom and Robert L. Wolen. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Clinical Chemistry, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.